Standard Life PLC (LON:SL) Rating Restated
They currently have a GBX 300.00 TP on Standard Life PLC (LON:SL). RBC Capital Markets’s target would suggest a potential downside of -15.85 % from the company’s current stock price. This was shown in a research report on Friday, 14 October.
LON:SL is now trading -5.07% lower at GBX 331.20 as of 01:27 London time. Standard Life PLC’s stock is down -11.16% in the last 200 days. It has underperformed the S&P 500 Index, which has gained 2.61% in the same time period.
Out of 18 brokers covering Standard Life PLC, 8 rate it a Buy, 10 indicate a Hold while 2 suggest a Sell. The highest target is GBX 465 and the lowest is GBX 300 according to Thomson/First Call. The 12-month mean target is GBX 355.28, which means upside potential of 7.27% over the current price.
LON:SL Price Chart & Trend
The stock price of Standard Life PLC decreased 11.16% over the last 200 days, and is in strong down trend. In the last 50 and 100 days, Standard Life PLC is up 10.33% and down 3.33%, respectively. Our stocks momentum model is shown on the price chart below.
Standard Life PLC (LON:SL) Profile
Standard Life plc is a United Kingdom-based investment company. The Company operates through four segments: Standard Life Investments, UK and Europe, India and China, and Other. The Standard Life Investments segment provides a range of investment products for individuals and institutional customers through various investment vehicles.
Standard Life PLC (LON:SL) traded down -5.07% on 14 October, hitting GBX 331.2. A total of 2.72 million shares of the company’s stock traded hands. This is down from average of 5.53 million shares. Standard Life PLC has a 52 week low of GBX 248.20 and a 52 week high of GBX 427.8. The company has a market cap of 6.54 billion GBX and a P/E ratio of 16.41.
Get the latest Standard Life PLC (LON:SL) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
Standard Life PLC - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.